Investigación
Educación
Soluciones
Iniciar sesión
ES
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Institute of Immunology
Junjian He has not added Biography.
If you are Junjian He and would like to personalize this page please email our Author Liaison for assistance.
PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness.
Vaccine Jul, 2023 | Pubmed ID: 37400286
An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy.
Nature cancer Apr, 2024 | Pubmed ID: 38609488
Third Military Medical University
Yao Lin*,1,2,
Shuai Yue*,3,
Yang Yang*,4,
Junjian He5,
Xiaofan Yang6,
Lilin Ye5,
Xiangyu Chen7
1Department of Urology, South China Hospital, Medical School, Shenzhen University,
2Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, School of Biomedical Engineering, Shenzhen University Medical School,
3Cancer Center, Daping Hospital & Army Medical Center of PLA, Third Military Medical University,
4Guangdong Provincial Key Laboratory of Immune Regulation and Immunotherapy, School of Laboratory Medicine and Biotechnology, Southern Medical University,
5Institute of Immunology, Third Military Medical University,
6Dermatology Hospital, Southern Medical University,
7Institute of Immunological Innovation and Translation, Chongqing Medical University
Privacidad
Condiciones de uso
Políticas
Contáctenos
RECOMIENDE A LA BIBLIOTECA
BOLETINES de JoVE
JoVE Journal
Colecciones de métodos
JoVE Encyclopedia of Experiments
Archivo
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de recursos académicos
Autores
Bibliotecarios
Acceso
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados